Selegiline is an oral drug, known commercially as Jumexil.
This drug is used to treat Parkinson’s disease, having great effects on the central nervous system and decreasing the ‘tremors’ characteristic of the disease.
Parkinson’s disease
Skull pain; fainting; hallucinations dizziness feeling of fall difficulty to perform voluntary movements; dry mouth stomach ache.
Risk of pregnancy C; Women who breastfeed; deep dementia; People over the age of 60 with abnormal involuntary movements; Severe psychosis; peptic ulcer.
Orally
adults